B-cell lymphoma-2 (BCL-2) is a member of the BCL-2 family of anti-apoptotic mitochondrial proteins and has been shown to enhance AML cell survival and therapeutic resistance. The gene discussed is BCL2; the disease is acute myeloid leukemia.